Literature DB >> 22751353

Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model.

Fadil Ozyener1, Merih Çetinkaya, Tulin Alkan, Bülent Gören, Ilker Mustafa Kafa, Mustafa Ayberk Kurt, Nilgun Koksal.   

Abstract

PURPOSE: The objective of this study was to compare the effects of two neuroprotective agents; melatonin, a free radical scavenger and topiramate, AMPA/kainate receptor antagonist, administered alone or in combination in neonatal hypoxic-ischemic model.
METHODS: After being anesthetized, 7-day-old pups underwent ischemia followed by exposure to hypoxia. The pups were divided into 4 groups in order to receive the vehicle, melatonin, topiramate and combination of topiramate and melatonin. These were administered intraperitoneally for three times; the first before ischemia, the second after hypoxia and the third 24 hours after the second dose. After sacrification, infarct volume and apoptosis were evaluated.
RESULTS: Percent infarcted brain volume was significantly reduced in rats which received drugs compared with those which received the vehicle. The number of TUNEL positive cells per unit area in hippocampus and cortex were markedly reduced in drug treated groups compared with control group. No significant differences were found regarding percent infarcted brain volume and number of TUNEL positive cells among drug-treated groups.
CONCLUSIONS: Melatonin and topiramate, administered either alone or in combination significantly reduced the percent infarcted brain volume and number of TUNEL positive cells suggesting that these agents may confer benefit in treatment of infants with hypoxic-ischemic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751353     DOI: 10.3233/RNN-2012-120217

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  13 in total

1.  Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants.

Authors:  Matteo Bruschettini; Olga Romantsik; Alvaro Moreira; David Ley; Bernard Thébaud
Journal:  Cochrane Database Syst Rev       Date:  2020-08-19

Review 2.  Pharmacological Approach for Neuroprotection After Cardiac Arrest-A Narrative Review of Current Therapies and Future Neuroprotective Cocktail.

Authors:  Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker
Journal:  Front Med (Lausanne)       Date:  2021-05-18

Review 3.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 4.  New horizons for newborn brain protection: enhancing endogenous neuroprotection.

Authors:  K Jane Hassell; Mojgan Ezzati; Daniel Alonso-Alconada; Derek J Hausenloy; Nicola J Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-06-10       Impact factor: 5.747

5.  Melatonin Suppresses Toll Like Receptor 4-Dependent Caspase-3 Signaling Activation Coupled with Reduced Production of Proinflammatory Mediators in Hypoxic Microglia.

Authors:  Linli Yao; Pengfei Lu; Eng-Ang Ling
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

6.  Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Authors:  Alejandro Romero; Eva Ramos; Paloma Patiño; Maria J Oset-Gasque; Francisco López-Muñoz; José Marco-Contelles; María I Ayuso; Alberto Alcázar
Journal:  Front Aging Neurosci       Date:  2016-11-23       Impact factor: 5.750

Review 7.  Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches.

Authors:  Olatz Arteaga; Antonia Álvarez; Miren Revuelta; Francisco Santaolalla; Andoni Urtasun; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

8.  Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia.

Authors:  Li Hu; Shutian Zhang; Haoyu Wen; Tianfeng Liu; Jian Cai; Dongshu Du; Danian Zhu; Fuxue Chen; Chunmei Xia
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

Review 9.  An Assessment of Melatonin's Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn.

Authors:  Daniel P Cardinali
Journal:  Front Synaptic Neurosci       Date:  2019-12-10

Review 10.  Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy.

Authors:  Brandon J Dixon; Cesar Reis; Wing Mann Ho; Jiping Tang; John H Zhang
Journal:  Int J Mol Sci       Date:  2015-09-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.